M onocrotaline-induced pulmonary hypertension (PH) has become a reliable and important animal model of pulmonary vascular disease (1). Monocrotaline is a toxic alkaloid extract from the Crotalaria plant. Rats characteristically develop pulmonary vascular smooth muscle hypertrophy, PH (average mean pulmonary arterial pressure [mPAP] ϭ 26 mm Hg), and right ventricular hypertrophy (average right ventricle/left ventricle and septum [RV/(LVϩS)] ratio ϭ 0.4) 4 wks after a single subcutaneous injection of monocrotaline (1, 2). In a more recently described model of PH, the combination of monocrotaline administration and left pneumonectomy leads to the development of severe PH (mPAP ϭ 46 mm Hg) and pulmonary arterial neointimal formation in the remaining lung and right ventricular hypertrophy (RV/ [LVϩS] ϭ 0.7) (3-5). These differences in the two models are thought to result from alterations in pulmonary blood flow and vascular shear stress, because, in pneumonectomized rats, the entire cardiac output flows to the remaining lung (6).
M onocrotaline-induced pulmonary hypertension (PH) has become a reliable and important animal model of pulmonary vascular disease (1) . Monocrotaline is a toxic alkaloid extract from the Crotalaria plant. Rats characteristically develop pulmonary vascular smooth muscle hypertrophy, PH (average mean pulmonary arterial pressure [mPAP] ϭ 26 mm Hg), and right ventricular hypertrophy (average right ventricle/left ventricle and septum [RV/(LVϩS)] ratio ϭ 0.4) 4 wks after a single subcutaneous injection of monocrotaline (1, 2) . In a more recently described model of PH, the combination of monocrotaline administration and left pneumonectomy leads to the development of severe PH (mPAP ϭ 46 mm Hg) and pulmonary arterial neointimal formation in the remaining lung and right ventricular hypertrophy (RV/ [LVϩS] ϭ 0.7) (3-5). These differences in the two models are thought to result from alterations in pulmonary blood flow and vascular shear stress, because, in pneumonectomized rats, the entire cardiac output flows to the remaining lung (6) .
Based on the above, the development of severe PH and neointimal formation in rats is thought to require a combination of vascular injury by monocrotaline and a change in hemodynamics. A surgical aortocaval fistula (ACF) results in a 30% to 80% increase in cardiac output in rats (7) and dogs (8) . Moreover, rats with an ACF have been shown to have an increased venous return to the right heart leading to increased pulmonary blood flow (9) . We therefore hypothesized that a surgical ACF would lead to increased pulmonary blood flow that might accelerate the development and progression of monocrotaline-induced PH in rats.
Contrary to our hypothesis, however, the current study demonstrates that the presence of a surgical ACF attenuates, rather than worsens, monocrotalineinduced PH in rats.
MATERIALS AND METHODS

Animal Model and Study Design
Thirteen-week-old male, 350-to 400-g, pathogen-free Sprague-Dawley rats were studied. Rats were randomly assigned to one of eight groups. Normal rats served as a reference control (group N) (n ϭ 6). Group F (n ϭ 6) underwent surgical ACF. Group P (n ϭ 6) underwent left pneumonectomy. Group PF (n ϭ 6) underwent left pneumonectomy and surgical ACF. Group M (n ϭ 6) received monocrotaline. Group MF (n ϭ 6) underwent surgical ACF and received monocrotaline. Group PM (n ϭ 6) underwent left pneumonectomy and received monocrotaline. Group PMF (n ϭ 6) underwent left pneumonectomy, surgical ACF, and then received monocrotaline.
Operative Procedures
Left Pneumonectomy. On day 0, groups P, PF, PM, and PMF underwent left pneumonectomy as previously described (4, 5) . Briefly, after the induction of anesthesia (atropine sulfate [50 g, intramuscularly], ketamine HCl [10 mg, intramuscularly], and xylazine [5 mg, subcutaneously]), rats were placed in a supine position. After oral endotracheal intubation with a 14-gauge catheter, anesthesia was maintained with inhalation halothane (0.5%) administered via a Harvard (Type 683, Harvard Apparatus, South Natick, MA) rodent ventilator (tidal volume 3.0 mL, FIO 2 ϭ 1.0, respiratory rate 60 per min, positive end-expiratory pressure 1 cm H 2 O). A left pneumonectomy was performed with aseptic technique. During surgery and during hemodynamic measurements, the rats were placed on a constant temperature-heating pad (36 to 38°C) (Braintree Scientific, Braintree, MA).
ACF. On day 0, groups F and MF underwent surgical ACF, and groups PF and PMF underwent left pneumonectomy followed by the creation of an ACF (10) . Through a midline abdominal incision, the abdominal aorta and inferior vena cava were exposed by blunt dissection. The aorta was clamped (0.5-cm caudal to the left renal artery) using a micro DeBakey bulldog clamp. An ACF was created by inserting a 20-gauge needle through the posterior and left lateral wall of the abdominal aorta and into the inferior vena cava at a point 1.5-cm distal to the renal artery bifurcation. The needle was withdrawn while one drop of cyanoacrylate glue (Krazy glue, TM DuPont, Atlantic Promotion, Longueuil, Quebec) was applied to seal the puncture in the posterior and left wall of the abdominal aorta. The patency of the ACF was verified by observing swelling of the inferior vena cava and the appearance of arterial blood in the inferior vena cava after release of the bulldog clamp. The midline incision was closed with 4.0 silk. On day 7, fistula patency was confirmed by auscultation of a systolic murmur in the abdomen. On the 35th postoperative day, the patency of the ACF was confirmed at laparotomy.
Monocrotaline Injection. On day 7, rats in groups M, MF, PM, and PMF received a single subcutaneous injection of monocrotaline (Sigma Chemical, St. Louis, MO) (60 mg/kg, dissolved in distilled water, pH adjusted to 7.40 with 0.5 N HCl). A prior study demonstrated that PH develops whether monocrotaline is given before or after pneumonectomy (3).
All 
Hemodynamic Studies and Tissue Preparation
On day 35, mean arterial blood pressure, right ventricular systolic blood pressure, and pulmonary arterial blood pressure were recorded as previously reported (4, 5) . Briefly, rats were anesthetized with ketamine HCl (10 mg, intramuscularly) and atropine sulfate (50 g, intramuscularly), and anesthesia was maintained with inhalation halothane (0.5%, by hood). An arterial catheter was placed in the left carotid artery by cutdown. An arterial blood gas sample (FIO 2 ϭ 0.24) was obtained. The right internal jugular vein was dissected and a modified pulmonary artery catheter (0.28-mm internal diameter, Tygon) was inserted under pressure waveform monitoring and measures of right ventricular systolic pressure and PAP were obtained.
Measurement of Aortic Flow
After endotracheal intubation, rats were ventilated for 6 mins (tidal volume 3.0 mL [or 1.8 mL in pneumonectomized rats], rate 60 per min, positive endexpiratory pressure 1 cm H 2 O, FIO 2 ϭ 0.5, 0.5% halothane). These ventilatory settings were chosen to provide maximal blood oxygenation so that between-group differences in pulmonary blood flow could not be attributed to between-group differences in PaO 2 , pH, and PaCO 2 . A median sternotomy was performed and the chest was opened. The ascending aorta was freed by careful blunt dissection. A Doppler blood flow probe (12-Fr, Carolina Medical Electronics, King, NC) was placed around the root of the ascending aorta and the aortic blood flow was measured in triplicate.
Calculated Pulmonary Blood Flow to the Right Lung
Animals in some groups had a pneumonectomy. Therefore, to determine whether our surgical procedures had caused a relative increase in pulmonary blood flow to the remaining lung, and to facilitate between-group comparisons, we estimated the pulmonary blood flow to the right lung in all animals. Because aortic flow equals pulmonary blood flow (in these animals that did not have rightto-left shunts), we calculated that the pulmonary blood flow to the right lung was equal to the aortic blood flow multiplied by the ratio of right lung dry weight to total lung dry weight.
Lung and Heart Pathology
The right lung, right ventricle and left ventricle plus septum were weighed, then fixed in 10% neutral buffered formalin. A vascular occlusion score was calculated for each animal by a blinded investigator (GJB). The lung was axially sectioned, processed, and embedded in paraffin wax. Five-micron sections were prepared and stained with elastin van Gieson. Twentyfive intraacinar arteries were evaluated in each animal. The severity of neointimal formation was quantified according to a standard scoring system used in this and other laboratories (3) (4) (5) . The absence of neointimal formation corresponded to a score of 0. The presence of neointimal proliferation causing Ͻ50% luminal narrowing was assigned a score of 1. The presence of neointimal proliferation Ͼ50% luminal narrowing was assigned a score of 2.
Statistical Analysis
Data are presented as means Ϯ standard deviations. Differences between groups were determined using two-way analysis of variance (ANOVA) and Newman-Keuls' tests, with statistical significance indicated by p Ͻ .05.
RESULTS
Forty-eight rats were studied. Twentyfour underwent surgical ACF, 24 underwent pneumonectomy, and 24 received monocrotaline (60 mg/kg, subcutaneously) ( Table 1 ). All rats underwent hemodynamic measurements and were killed on postoperative day 35. Perioperative mortality was zero. There was no death before study completion.
Physiology
ACF Increased PaO 2 . Rats with ACF had higher PaO 2 than matched animals without ACF (p Ͻ .001, by ANOVA). Groups F (100 Ϯ 7 mm Hg), PF (91 Ϯ 2 mm Hg), MF (94 Ϯ 5 mm Hg), and PMF (84 Ϯ 8 mm Hg) had higher PaO 2 than the matched groups of groups N (80 Ϯ 4 mm Hg), P (72 Ϯ 8 mm Hg), M (69 Ϯ 7 mm Hg) (p Ͻ .01), and PM (71 Ϯ 14 mm Hg), respectively (p Ͻ .05) (Fig. 1A) .
There was no difference in pH and PaCO 2 among the groups. When arterial blood gas samples were obtained during mechanical ventilation at FIO 2 ϭ 0.5, there was no between-group difference in pH, PaO 2 , PaCO 2 among the groups. We measured aortic flow under these conditions (mechanical ventilation, FIO 2 ϭ 0.5) so that between-group differences in calculated pulmonary blood flow could not be attributed to between-group differences in pH, PaO 2 , or PaCO 2 .
ACF Increased Aortic Blood Flow. The presence of an ACF consistently led to increased aortic blood flow (p Ͻ .001, by ANOVA) (Fig. 1B) . Groups PF (68 Ϯ 13 mL/min), MF (75 Ϯ 14 mL/min) and PMF (102 Ϯ 38 mL/min) had increased aortic blood flow compared with groups P (48 Ϯ 5 mL/min) (p Ͻ .01), M (59 Ϯ 5 mL/min) (p Ͻ .01), and PM (30 Ϯ 7 mL/min) (p Ͻ .05), respectively (Fig. 1B) . Group F (84 Ϯ 26 mL/min) had higher aortic blood flow than group N (65 Ϯ 13 mL/min), but the difference did not reach statistical significance using Newman-Keuls' test. Rats in group PM demonstrated significantly lower aortic blood flow compared with groups M, P, and N (p Ͻ .01), perhaps reflecting low output cardiac failure in these animals with severe PH (Fig. 1B) . There were no significant between-group differences in systemic arterial blood pressure (data not shown).
Calculated Pulmonary Blood Flow to the Right Lung. The presence of an ACF consistently led to increased calculated pulmonary blood flow to the right lung (p Ͻ .001, by ANOVA). Groups PF (68 Ϯ 13 mL/min), MF (53 Ϯ 10 mL/min), and PMF (102 Ϯ 38 mL/min) had increased calculated pulmonary blood flow to the right lung compared with groups P (48 Ϯ 5 mL/min) (p Ͻ .01), M (38 Ϯ 2 mL/min) (p Ͻ .01), and PM (30 Ϯ 7 mL/min) (p Ͻ .05), respectively (Fig. 1C) . Group F (54 Ϯ 18 mL/min) had a higher calculated blood flow to the right lung than group N (40 Ϯ 10 mL/min), but the difference did not reach statistical significance using Newman-Keuls' test. Rats in group P demonstrated a trend toward a higher calculated pulmonary blood flow to the right lung than group N (p ϭ .10).
Rats with ACF Have Lower mPAP. Rats with ACF had lower mPAPs than matched animals without ACF(p Ͻ .001, by ANOVA). The decrease in mPAP with ACF occurred in rats that received pneumonectomy, monocrotaline, or pneumonectomy plus monocrotaline, but not in the untreated rats (Fig. 2) . Animals that received monocrotaline alone (group M) developed moderate pulmonary arterial hypertension (mPAP ϭ 26 Ϯ 2 mm Hg) (Fig. 2) , as previously described (1). Pneumonectomized rats that received monocrotaline developed severe pulmonary arterial hypertension (mPAP ϭ 42 Ϯ 4 mm Hg), similar to published data (4, 5) . However, groups PF (15 Ϯ 2 mm Hg) and MF (18 Ϯ 2 mm Hg) had lower PAP than matched groups: groups P (17 Ϯ 1 mm Hg) and M (26 Ϯ 2 mm Hg), respectively (Fig. 2) (p Ͻ .01) . Rats in group PMF (33 Ϯ 6 mm Hg) had lower PAP than group PM (42 Ϯ 4 mm Hg) (Fig. 2) (p Ͻ .05). Group N represents normal rats (n ϭ 6), group F underwent aortocaval fistula (ACF) (n ϭ 6), group P underwent left pneumonectomy (n ϭ 6), group PF underwent left pneumonectomy and the creation of an ACF (n ϭ 6), group M received monocrotaline (n ϭ 6), group MF underwent ACF and received monocrotaline (n ϭ 6), group PM underwent left pneumonectomy and received monocrotaline (n ϭ 6), and group PMF underwent left pneumonectomy and the creation of an ACF and then received monocrotaline (n ϭ 6). ##p Ͻ .001 by two-way analysis of variance, and *p Ͻ .05, **p Ͻ .01 by Newman-Keuls' tests. 
N, normal; F, surgical aortocaval fistula; P, left pneumonectomy; PF, left pneumonectomy and surgical aortocaval fistula; M, monocrotaline; MF, surgical aortocaval fistula and monocrotaline; PM, left pneumonectomy and monocrotaline; PMF, left pneumonectomy, surgical aortocaval fistula, and monocrotaline.
ACF Attenuates the Development of Right Ventricular Hypertrophy in Rats.
Right ventricular hypertrophy develops as a compensatory response to chronic pulmonary arterial hypertension. Rats with ACF had a significantly lower RV/ (LVϩS) ratio (p ϭ .003, by ANOVA). The RV/(LVϩS) ratio is 0.25 Ϯ 0.03 in normal rats, and an RV/(LVϩS) ratio Ͼ0.5 indicates right ventricular hypertrophy (11) . Rats that received monocrotaline alone, group M (0.36 Ϯ 0.04), had higher RV/ (LVϩS) compared with normal rats, group N (0.25 Ϯ 0.03) (p Ͻ .01) ( Table 2 ). There was no significant difference in RV/ (LVϩS) between rats with ACF (group F) and normal rats (group N). Pneumonectomized rats that received monocrotaline (group PM) demonstrated marked right ventricular hypertrophy, as previously described (11, 12) (Table 2 ). The presence of ACF in group PMF (0.53 Ϯ 0.10) was associated with significantly lower RV/ (LVϩS) than group PM (0.70 Ϯ 0.08) (p Ͻ .01) (Table1). These results suggest that an ACF protects against the development of right ventricular hypertrophy in an experimental model of PH.
Histopathology
ACF Protects Against the Development of Neointimal Proliferation. Rats
with ACF had significantly lower vascular occlusion scores (p ϭ .037, by ANOVA). Animals that did not receive monocrotaline (groups N, F, P, and PF) demonstrated rare neointimal formation (Fig.  3) . Animals that received monocrotaline group M (vascular occlusion score ϭ 1.06 Ϯ 0.5) (Fig. 3) , and particularly pneumonectomized animals that received monocrotaline (group PM) (Fig. 3D) demonstrated marked changes of neointimal proliferation. Vascular occlusion scores in group PMF (1.77 Ϯ 0.1) were significantly lower than in group PM (1.96 Ϯ 0.04) (p Ͻ .05) (Fig. 3E ). An ACF attenuates the development of PH and neointimal proliferation in this disease model.
DISCUSSION
In this report, we demonstrate that the presence of a surgical ACF attenuates, rather than worsens, the development of monocrotaline-induced PH in rats. This effect was also evident in rats that received monocrotaline combined with pneumonectomy. Based on the effects of pneumonectomy in the monocrotaline model, we initially hypothesized that the increased pulmonary blood flow that accompanies an ACF, might lead to an increase in pulmonary arterial pressure in rats that receive monocrotaline. We also had anticipated that the presence of an ACF would contribute to the combined effects of pneumonectomy and monocrotaline administration on the development of pulmonary arterial neointimal proliferation and PH. In contrast, our findings demonstrate that the presence of an ACF protects against, rather than accelerates, monocrotaline-induced pulmonary arterial hypertension in rats.
Our results in rats without ACF are consistent with published data on the development of monocrotaline-induced PH. First, rats that receive a single injection of monocrotaline develop PH (average mPAP ϭ 26 mm Hg) and right ventricular hypertrophy (average RV/[LVϩS] ϭ 0.4) similar to the current data (3, 12) . Second, other studies of pneumonectomized rats that receive monocrotaline (by our laboratory and others) demonstrate severe pulmonary arterial hypertension (mPAP ϭ 42 mm Hg), right ventricular hypertrophy (RV/[LVϩS] ϭ 0.7), and pulmonary arterial neointimal formation, similar to the current results (3) (4) (5) . Finally, previous studies of the hemodynamic effects of ACF demonstrate increases in aortic blood flow and PaO 2 that are similar to the current data (8) . Consistent with previous studies, we demonstrate that a surgical ACF alone in rats slightly increases mPAP from 17 to 20.5 mm Hg, but does not lead to the development of significant (mPAP Ͼ25 mm Hg) pulmonary arterial hypertension (9) .
The development of experimental pulmonary vascular neointimal formation and severe PH in rats is thought to require a combination of vascular injury by monocrotaline and an increase in vascular shear stress. When monocrotaline administration is combined with left pneumonectomy, the entire cardiac output flows to the remaining right lung, and severe pulmonary arterial hypertension and neointimal formation develop. Some authors suggest that a hemodynamic effect, rather than an effect of pneumonectomy, has a dominant role in neointimal formation (3, 12) . The creation of a subclavian artery to left pulmonary artery shunt also leads to neointimal formation Measurements of mean pulmonary artery pressures (mPAP). Group N represents normal rats (n ϭ 6), group F underwent aortocaval fistula (ACF) (n ϭ 6), group P underwent left pneumonectomy (n ϭ 6), group PF underwent left pneumonectomy and the creation of an ACF (n ϭ 6), group M received monocrotaline (n ϭ 6), group MF underwent ACF and received monocrotaline (n ϭ 6), group PM underwent left pneumonectomy and received monocrotaline (n ϭ 6), and group PMF underwent left pneumonectomy and the creation of an ACF and then received monocrotaline (n ϭ 6). ##p Ͻ .001 by two-way analysis of variance, and **p Ͻ .01 by NewmanKeuls' tests. in the right lung in the monocrotalineinjected rats (12) . Left pneumonectomy, and a subclavian artery to left pulmonary artery shunt both lead to increased pulmonary blood flow to the right lung that might explain the more severe PH that is reported when these procedures are combined with monocrotaline administration (12) . The data in this study suggest that increased pulmonary blood flow per se, does not exacerbate monocrotalineinduced PH.
A variety of experimental models of PH exist. In some protocols, pulmonary arterial hypertension is created via an aortopulmonary shunt (13) , in others via an anastomosis between the left upper lobe pulmonary artery and the aorta (14) , or in others the left subclavian artery is anastomosed to the left pulmonary artery (12) . These surgical procedures result in increased blood pressure (systemic arterial pressure) in the pulmonary arterial tree distal to the shunt. In lambs with an aortopulmonary shunt, the pulmonary arterial pressure is significantly higher (45 mm Hg) than controls (16 mm Hg) (13) . Histology reveals medial hypertrophy, abnormal extension of smooth muscle distally into the walls of the intraacinar arteries, and increased numbers of intraacinar arteries in the lungs of the shunt group (13) . In a sheep model of isolated PH in the left upper lobe, through an anastomosis between the left upper lobe pulmonary artery and the aorta (14) , the left upper lobe develops extensive vascular remodeling with intimal proliferation and medial hypertrophy, and lobar PH (mPAP ϭ 76 mm Hg). However, although the shunt between the left upper lobe pulmonary artery to the aorta leads to increased cardiac output (7.1 vs. 5.1 L/min in controls), the pressure in the main pulmonary artery remains normal (20 vs. 17 mm Hg in controls) (14) . In contrast, the creation of a carotid artery-jugular vein shunt in newborn lambs increases cardiac output substantially (4.0 vs. 2.0 L/min in controls) but produces only small increases in mPAP (23 vs. 10 mm Hg in controls) (15) . Lambs injected with monocrotaline pyrrole have diminished cardiac output (1.57 L/min) and modest increases of mPAP (30 mm Hg) (15) . The effect of carotid artery-jugular vein shunt on the development of monocrotaline pyrroleinduced PH has not been described. Collectively, these studies suggest that systemic to pulmonary artery shunts cause severe PH in the pulmonary artery distal to the shunt, perhaps because they introduce blood at systemic pressures, but 0) . B, an example of a grade 1 neointimal lesion (Ͻ50% occlusion) seen in rats that received monocrotaline alone (group M). C, an example of grade 1 neointimal lesion (Ͻ50% occlusion) seen in rats that underwent left pneumonectomy and the creation of an aortocaval fistula (ACF) and then received monocrotaline (group PMF). D, an example of a grade 2 neointimal lesion (Ͼ50% occlusion) seen in rats that underwent left pneumonectomy and received monocrotaline (group PM). All photomicrographs (ϫ400), elastin van Gieson stain. E, the vascular occlusion score is the average score for 25 intraacinar pulmonary arteries. Group N represents normal rats (n ϭ 6), group F underwent ACF (n ϭ 6), group P underwent left pneumonectomy (n ϭ 6), group PF underwent left pneumonectomy and the creation of an ACF (n ϭ 6), group M received monocrotaline (n ϭ 6), group MF underwent ACF and received monocrotaline (n ϭ 6), group PM underwent left pneumonectomy and received monocrotaline (n ϭ 6), and group PMF underwent left pneumonectomy and the creation of an ACF and then received monocrotaline (n ϭ 6). Group PMF had significantly lower vascular occlusion scores than group PM. #p Ͻ .05 by two-way analysis of variance, and *p Ͻ .05 by Newman-Keuls' tests. large arteriovenous shunts lead to only modest increases in mPAP. The current data suggest that smaller arteriovenous fistulas (leading to a 30% increase in cardiac output) do not significantly increase mPAP.
Vascular shear stress, a history of exposure to toxins (diet pills, monocrotaline), and genetic susceptibility have each been implicated in the development and progression of PH (16 -18) . Some data suggest that the coexistence of two or more of these factors may lead to the development of primary PH. For instance, although a history of diet pill use is associated with an increased occurrence of primary PH, the prevalence of primary PH in subjects who take diet pills remains very low (40 per million) (19) . In addition, only 15% of obligate carriers of the gene for familial primary PH develop the disease, suggesting that other factors, such as vascular shear stress, hemodynamic factors, or endothelial injury, are necessary for the development of PH (18, 20, 21) . Herein, we confirm that an arteriovenous shunt does not cause PH. Moreover, this study reveals that overcirculation via an ACF attenuates, rather than worsens, the development of monocrotaline-induced PH. Increases in cardiac output can modulate the development of pulmonary arterial hypertension in a complex manner, in some cases leading to attenuation of disease.
The presence of an ACF might prevent, or ameliorate, pulmonary arterial neointimal proliferation and PH by causing an increase in mixed venous blood oxygen tension. Oxygen-sensitive chemoreceptors located in the pulmonary arteriole are thought to be the dominant controllers of pulmonary vascular tone (22) . Chronic pulmonary arterial hypoxemia causes pulmonary vasoconstriction, pulmonary arterial medial hypertrophy, and PH (11) . Increases in pulmonary arterial blood oxygen tension might lead to pulmonary arterial vasodilatation or decrease the vascular proliferate effects of endothelial injury. Further study of the influence of hemodynamic factors on the development of PH is required.
